Source: Annual Congress 2011 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. R. Parra, F. Lin, V. Capelozzi (São Paulo, Brazil). Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis. Eur Respir J 2011; 38: Suppl. 55, 640

Member's Comments

No comment yet.

Related content which might interest you: Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Survival and prognostic factors in progressive systemic sclerosis with lung involvement Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Etiologic factors in patients with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 CCL18 as marker of disease progression in systemic sclerosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis Source: Eur Respir J 2009; 34: 1376-1382 Year: 2009 Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018 Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Source: Eur Respir J 2011; 38: 1355-1360 Year: 2011 Serum‘s factors inhibit erythropoiesis in patients with idiopathic pulmonary fibrosis(IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018 Year: 2018 Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 The role of TLR4 gene expression in pathogenesis of multiple organ dysfunction syndrome in the elderly rats Source: Eur Respir J 2005; 26: Suppl. 49, 559s Year: 2005